Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
Background: Interaction between multiple myeloma (MM) cells and proximal monocytes is expected during plasma cell proliferation. However, the role of monocyte subsets in the disease progression is unknown. Objective: This study evaluated circulating monocyte populations in MM patients and their cor...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2021-08-01
|
Series: | African Journal of Laboratory Medicine |
Subjects: | |
Online Access: | https://ajlmonline.org/index.php/ajlm/article/view/1296 |
id |
doaj-813eadb309c54aef8d01b5cb7af0684e |
---|---|
record_format |
Article |
spelling |
doaj-813eadb309c54aef8d01b5cb7af0684e2021-09-03T08:55:31ZengAOSISAfrican Journal of Laboratory Medicine2225-20022225-20102021-08-01101e1e810.4102/ajlm.v10i1.1296336Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic markerAsmaa M. Zahran0Hanaa Nafady-Hego1Sawsan M. Moeen2Hanan A. Eltyb3Mohammed M. Wahman4Asmaa Nafady5Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, AssiutDepartment of Microbiology and Immunology, Faculty of Medicine, Assiut University, AssiutDepartment of Internal Medicine, Clinical Haematology Unit, Faculty of Medicine, Assiut University, AssiutDepartment of Medical Oncology, South Egypt Cancer Institute, Assiut University AssiutDepartment of Clinical Oncology, South Valley University, QenaDepartment of Clinical and Chemical Pathology, Qena Faculty of Medicine, South Valley University, QenaBackground: Interaction between multiple myeloma (MM) cells and proximal monocytes is expected during plasma cell proliferation. However, the role of monocyte subsets in the disease progression is unknown. Objective: This study evaluated circulating monocyte populations in MM patients and their correlation with disease severity. Methods: Peripheral monocytes from 20 patients with MM attending Assiut University Hospital in Assiut, Egypt, between October 2018 and August 2019 were processed using a flow cytometry procedure and stratified using the intensity of expression of CD14 and CD16 into classical (CD16−CD14++), intermediate (CD16+CD14++), and non-classical (CD16++CD14+) subsets. The data were compared with data from 20 healthy control participants with comparable age and sex. Results: In patients with MM, the percentage of classical monocytes was significantly lower (mean ± standard error: 77.24 ± 0.66 vs 83.75 ± 0.5), while those of non-classical (12.44 ± 0.5 vs 8.9 ± 0.34) and intermediate (10.3 ± 0.24 vs 7.4 ± 0.29) monocytes were significantly higher when compared with those of controls (all p 0.0001). Proportions of non-classical and intermediate monocytes correlated positively with serum levels of plasma cells, M-protein, calcium, creatinine and lactate dehydrogenase, and correlated negatively with the serum albumin level. Proportions of classical monocytes correlated positively with albumin level and negatively correlated with serum levels of M-protein, plasma cells, calcium, creatinine, and lactate dehydrogenase. Conclusion: Circulating monocyte subpopulations are skewed towards non-classical and intermediate monocytes in MM patients, and the intensity of this skewness increases with disease severity.https://ajlmonline.org/index.php/ajlm/article/view/1296multiple myelomaclassical monocytesintermediate monocytesnon-classical monocytesflow cytometry |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Asmaa M. Zahran Hanaa Nafady-Hego Sawsan M. Moeen Hanan A. Eltyb Mohammed M. Wahman Asmaa Nafady |
spellingShingle |
Asmaa M. Zahran Hanaa Nafady-Hego Sawsan M. Moeen Hanan A. Eltyb Mohammed M. Wahman Asmaa Nafady Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker African Journal of Laboratory Medicine multiple myeloma classical monocytes intermediate monocytes non-classical monocytes flow cytometry |
author_facet |
Asmaa M. Zahran Hanaa Nafady-Hego Sawsan M. Moeen Hanan A. Eltyb Mohammed M. Wahman Asmaa Nafady |
author_sort |
Asmaa M. Zahran |
title |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker |
title_short |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker |
title_full |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker |
title_fullStr |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker |
title_full_unstemmed |
Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker |
title_sort |
higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in egypt: a possible prognostic marker |
publisher |
AOSIS |
series |
African Journal of Laboratory Medicine |
issn |
2225-2002 2225-2010 |
publishDate |
2021-08-01 |
description |
Background: Interaction between multiple myeloma (MM) cells and proximal monocytes is expected during plasma cell proliferation. However, the role of monocyte subsets in the disease progression is unknown.
Objective: This study evaluated circulating monocyte populations in MM patients and their correlation with disease severity.
Methods: Peripheral monocytes from 20 patients with MM attending Assiut University Hospital in Assiut, Egypt, between October 2018 and August 2019 were processed using a flow cytometry procedure and stratified using the intensity of expression of CD14 and CD16 into classical (CD16−CD14++), intermediate (CD16+CD14++), and non-classical (CD16++CD14+) subsets. The data were compared with data from 20 healthy control participants with comparable age and sex.
Results: In patients with MM, the percentage of classical monocytes was significantly lower (mean ± standard error: 77.24 ± 0.66 vs 83.75 ± 0.5), while those of non-classical (12.44 ± 0.5 vs 8.9 ± 0.34) and intermediate (10.3 ± 0.24 vs 7.4 ± 0.29) monocytes were significantly higher when compared with those of controls (all p 0.0001). Proportions of non-classical and intermediate monocytes correlated positively with serum levels of plasma cells, M-protein, calcium, creatinine and lactate dehydrogenase, and correlated negatively with the serum albumin level. Proportions of classical monocytes correlated positively with albumin level and negatively correlated with serum levels of M-protein, plasma cells, calcium, creatinine, and lactate dehydrogenase.
Conclusion: Circulating monocyte subpopulations are skewed towards non-classical and intermediate monocytes in MM patients, and the intensity of this skewness increases with disease severity. |
topic |
multiple myeloma classical monocytes intermediate monocytes non-classical monocytes flow cytometry |
url |
https://ajlmonline.org/index.php/ajlm/article/view/1296 |
work_keys_str_mv |
AT asmaamzahran higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker AT hanaanafadyhego higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker AT sawsanmmoeen higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker AT hananaeltyb higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker AT mohammedmwahman higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker AT asmaanafady higherproportionofnonclassicalandintermediatemonocytesinnewlydiagnosedmultiplemyelomapatientsinegyptapossibleprognosticmarker |
_version_ |
1717817598985371648 |